The efficacy and safety of anlotinib plus PD-1 inhibitor in locally advanced/metastatic esophageal squamous cell carcinoma (ESCC) patients who progressed on prior immune checkpoint inhibitors (ICIs): a retrospective real-world study (NCT 04984096)

Authors

Hongxuan Li (ORCID: https://orcid.org/0000-0001-6751-1970)
Yan Cheng (ORCID: https://orcid.org/0000-0002-7019-052X)
Zhigang Li (ORCID: https://orcid.org/0000-0001-5086-5334)
Wen Yu (ORCID: https://orcid.org/0000-0002-2338-4663)
Jun Liu (ORCID: https://orcid.org/0000-0001-5288-3042)
Ming Zhang (ORCID: https://orcid.org/0000-0002-6050-6463)
Xiumei Ma
Jian Wu (ORCID: https://orcid.org/0000-0002-3394-1507)
Feng Wen (ORCID: https://orcid.org/0000-0003-0642-0164)
Xiaolong Fu (ORCID: https://orcid.org/0000-0003-0093-8659)
Lei Zhao (ORCID: https://orcid.org/0000-0002-9919-5981)
Xueru Zhu

Institutions

Tongji University (CN)
Shanghai Jiao Tong University (CN)
Renji Hospital (CN)
Shanghai Chest Hospital (CN)
Shanghai Tenth People's Hospital (CN)

Publication Details

Journal: Annals of Medicine
Published: 2024-12-23
DOI: https://doi.org/10.1080/07853890.2024.2443811
Citations: 4
Primary Topic: Esophageal Cancer Research and Treatment
Type: article
Field-Weighted Citation Impact: 2.29

Funders

National Natural Science Foundation of China
Science and Technology Commission of Shanghai Municipality

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The efficacy and safety of anlotinib plus PD-1 inhibitor in locally advanced/metastatic esophageal squamous cell carcinoma (ESCC) patients who progressed on prior immune checkpoint inhibitors (ICIs): a retrospective real-world study (NCT 04984096)

Hongxuan Li, Yan Cheng, Zhigang Li, Wen Yu et al.

Dec 23, 2024

4 citations

Annals of Medicine

Esophageal Cancer Research and Treatment

2.29

article

The efficacy and safety of anlotinib plus PD-1 inhibitor in locally advanced/metastatic esophageal squamous cell carcinoma (ESCC) patients who progressed on prior immune checkpoint inhibitors (ICIs): a retrospective real-world study (NCT 04984096)

Hongxuan Li, Yan Cheng, Zhigang Li, Wen Yu, Jun Liu, Ming Zhang, Xiumei Ma, Jian Wu, Feng Wen, Xiaolong Fu, Lei Zhao, Xueru Zhu

December 23, 2024article en

4 citations

Abstract

No abstract available for this paper.

Annals of MedicineVol. 57(1)

Tongji University (CN), Shanghai Jiao Tong University (CN), Renji Hospital (CN), Shanghai Chest Hospital (CN), Shanghai Tenth People's Hospital (CN)

National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality

Good health and well-being

Openalex Percentile: Top 11%

Esophageal Cancer Research and Treatment

2.29

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.